CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-02 | MANHARD KIMBERLY Executive VP, Drug Development | Sale | −5,900 | $37.51 | $221K | 100 |
| 2018-07-02 | MANHARD KIMBERLY Executive VP, Drug Development | Sale | −100 | $38.85 | $4K | 0 |
| 2018-07-02 | MANHARD KIMBERLY Executive VP, Drug Development | Exercise or conversion · Employee Stock Option (Right to Buy) | −6,000 | 88,416 | ||
| 2018-07-02 | HOFFMAN ROBERT CFO & SVP, Finance | Exercise or conversion | +30,000 | $15.30 | $459K | 31,280 |
| 2018-07-02 | HOFFMAN ROBERT CFO & SVP, Finance | Sale | −28,940 | $38.15 | $1.1M | 2,340 |
| 2018-07-02 | HOFFMAN ROBERT CFO & SVP, Finance | Sale | −1,060 | $38.80 | $41K | 1,280 |
| 2018-07-02 | HOFFMAN ROBERT CFO & SVP, Finance | Exercise or conversion · Employee Stock Option (Right to Buy) | −30,000 | 100,000 | ||
| 2018-07-02 | Rosen Robert President | Exercise or conversion | +95,531 | $7.20 | $688K | 98,171 |
| 2018-07-02 | Rosen Robert President | Sale | −92,131 | $38.13 | $3.5M | 6,040 |
| 2018-07-02 | Rosen Robert President | Sale | −3,400 | $38.75 | $132K | 2,640 |
| 2018-07-02 | Rosen Robert President | Exercise or conversion · Employee Stock Option (Right to Buy) | −95,531 | 600,000 | ||
| 2018-06-29 | Rosen Robert President | Exercise or conversion | +129,469 | $7.20 | $932K | 132,109 |
| 2018-06-29 | Rosen Robert President | Sale | −75,661 | $39.14 | $3.0M | 56,448 |
| 2018-06-29 | Rosen Robert President | Sale | −51,696 | $40.17 | $2.1M | 4,752 |
| 2018-06-29 | Rosen Robert President | Sale | −2,112 | $41.39 | $87K | 2,640 |
| 2018-06-29 | Rosen Robert President | Exercise or conversion · Employee Stock Option (Right to Buy) | −129,469 | 695,531 | ||
| 2018-06-21 | Quart Barry D Chief Executive Officer | Exercise or conversion | +50,000 | $9.05 | $453K | 119,600 |
| 2018-06-21 | Quart Barry D Chief Executive Officer | Sale | −50,000 | $39.05 | $2.0M | 69,600 |
| 2018-06-21 | Quart Barry D Chief Executive Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −50,000 | 250,000 | ||
| 2018-04-30 | HOFFMAN ROBERT CFO & SVP, Finance | Other acquisition | +744 | $13.22 | $10K | 1,280 |
Page 32 of 38 · 746 trades